Remove Cannabinoids Remove Clinical Trials Remove Food Remove Treatment
article thumbnail

Epilepsy and MMJ: Exploring the Promising Treatment Benefits

MMJ Recs

While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).

Epilepsy 105
article thumbnail

ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

Cannabis Law Report

Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

Cannabis Law Report

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

article thumbnail

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures

LifeCannMD

The most compelling evidence of the effectiveness of Medical Marijuana in treating epilepsy comes from clinical trials. Food and Drug Administration (FDA) for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome.

article thumbnail

ANANDA Scientific and David Geffen School of Medicine UCLA Announce Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD)

Cannabis Law Report

Food and Drug Administration (FDA) for this trial. Pre-clinical and initial clinical studies show that ANANDA’s Liquid Structure technology (licensed from Lyotropic Delivery Systems (LDS) Ltd. . & LOS ANGELES–(BUSINESS WIRE)– ANANDA Scientific Inc. , ABOUT ANANDA SCIENTIFIC.

article thumbnail

FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials

Otherside Farms

In San Francisco and New York City, the physician-led pediatric studies will assess the viability of a purified cannabidiol as an anti-seizure treatment among patients with various forms of epilepsy. Food and Drug Administration (FDA) may approve more as the studies progress. In the upcoming U.S.

article thumbnail

Is Cannabis a Viable Mental Health Treatment Option? Part 3 of 3: Anxiety

Kind Meds (Cannabis Education Blog)

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111